Fenimore Christopher R.
Regeneron Pharmaceuticals Inc · EVP Finance CFO
Fenimore Christopher R. is listed in filings as EVP Finance CFO at Regeneron Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Dec 9, 2025, including sale activity. Recent filings connect the profile to Regeneron Pharmaceuticals Inc (REGN). The current snapshot covers public activity from Aug 29, 2024 to Dec 9, 2025. Reported amounts are shown as $707.2K to $358.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3M2.2k shares | SellAug 28, 2024 | $1,204.71 | $664.45 | |
| $1M928 shares | SellAug 28, 2024 | $1,205.49 | $664.45 | |
| $923k766 shares | SellAug 28, 2024 | $1,205.44 | $664.45 | |
| $543k450 shares | SellAug 28, 2024 | $1,206.15 | $664.45 | |
| $283k235 shares | SellAug 28, 2024 | $1,205.67 | $664.45 | |
| $275k228 shares | SellAug 28, 2024 | $1,204.79 | $664.45 | |
| $241k200 shares | SellAug 28, 2024 | $1,206.70 | $664.45 | |
| $241k200 shares | SellAug 28, 2024 | $1,206.67 | $664.45 | |
| $241k200 shares | SellAug 28, 2024 | $1,206.30 | $664.45 |